NC410
Solid tumors (e.g., colorectal, ovarian, pancreatic)
Key Facts
Indication
Solid tumors (e.g., colorectal, ovarian, pancreatic)
Phase
Phase 1/2
Status
Active
Company
About NextCure
NextCure is a clinical-stage biotech focused on discovering and developing first-in-class immunomedicines for cancer and immune-related diseases. Founded on pioneering Yale University research, the company employs its proprietary FIND platform to systematically identify novel immunosuppressive targets beyond the PD-1/CTLA-4 axis. Its strategy targets patient populations unresponsive to existing immunotherapies, with a pipeline led by candidates against Siglec-15 and LAIR-1. The company went public in 2019 and is navigating clinical development with a focus on novel biology.
View full company profile